First-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspective

scientific article published on October 2009

First-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspective is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.2174/138945009789577936
P698PubMed publication ID19663768

P50authorAntonio PalumboQ87013105
P2093author name stringMario Boccadoro
Pellegrino Musto
Luca Baldini
Francesco Di Raimondo
Fortunato Morabito
Francesca Gay
Maria Teresa Petrucci
Fiorella D'Auria
Michele Cavo
Patrizia Tosi
Sara Bringhen
Tommaso Caravita
Massimo Offidani
Giuseppe Pietrantuono
P2860cites workSingle autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trialQ46745193
P433issue10
P921main subjectmultiple myelomaQ467635
P304page(s)906-922
P577publication date2009-10-01
P1433published inCurrent Drug TargetsQ15724627
P1476titleFirst-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspective
P478volume10

Reverse relations

cites work (P2860)
Q51808808EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.
Q38586922Targeting B-cell maturation antigen in multiple myeloma